Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 8, 2024. (Total: 231257Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Sarcoma and Stk11[original query]
Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations.
Clinical chemistry 2014 Jul 60 (7): 1004-11.
Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory
KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Jan .
Hwang David H, Sholl Lynette M, Rojas-Rudilla Vanesa, Hall Dimity L, Shivdasani Priyanka, Garcia Elizabeth P, MacConaill Laura E, Vivero Marina, Hornick Jason L, Kuo Frank C, Lindeman Neal I, Dong F
Survival analysis in Caucasian pulmonary adenocarcinoma patients based on differential targets between Caucasian and Asian population.
Saudi journal of biological sciences 2018 Jul 25 (5): 1003-1006.
Zhu Zheng, Liang Zhigang, Tong Jichun, Mao Xiaoliang, Yin Yajun, Manor Lydia C, Shen Zhen
[Genetic Profile of Young Chinese Patients with Lung Adenocarcinoma].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2020 Apr 23 (4): 239-246.
Liang Yu, Hou Helei, Jiang Man, Zhang Chuantao, Liu Dong, Zhang Xiaoch
A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma.
Frontiers in oncology 2020 10 10 559896.
Xiang Luochengling, Fu Xiao, Wang Xiao, Li Wenyuan, Zheng Xiaoqiang, Nan Kejun, Tian T
Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ?50%: real-world data.
Oncoimmunology 2021 2 10 (1): 1865653.
Dudnik Elizabeth, Moskovitz Mor, Rottenberg Yakir, Lobachov Anastasiya, Mandelboim Rinat, Shochat Tzippy, Urban Damien, Wollner Mira, Nechushtan Hovav, Rotem Ofer, Zer Alona, Daher Sameh, Bar Jair,
Molecular Characteristics and the Effect of KRAS Mutation on the Prognosis of Immunotherapy in Non-Small Cell Lung Cancer in Xinjiang, China.
OncoTargets and therapy 2022 9 15 1021-1032.
Gu Guomin, Yu Bo, Wan Hua, Lu Suqiong, Zhu Xiaodan, Zhao Yan, Fuxi Yujing, Liu Chunli
The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer.
Cancer medicine 2022 4 11 (19): 3581-3592.
Chen Hanxiao, Huang Dingzhi, Lin Gen, Yang Xue, Zhuo Minglei, Chi Yujia, Zhai Xiaoyu, Jia Bo, Wang Jingjing, Wang Yuyan, Li Jianjie, An Tongtong, Wu Meina, Wang Ziping, Zhao J
TOP